Miller Fisher syndrome in the course of an acute pneumonia by Mycoplasma pneumoniae;Síndrome de Miller Fisher que complica una neumonía aguda por Mycoplasma pneumoniae

Revista de Neurologia

Volumn 36, Issue 3, 2003, Pages 235-237

  Sánchez Arjona, M Bernal ^a,b   Franco Macias E ^a   Villalobos Chaves, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b NONE   (Spain)

Author keywords

Guillain Barr syndrome; Miller Fisher syndrome; Mycoplasma pneumoniae

Indexed keywords

CEFTRIAXONE; ERYTHROMYCIN; IMMUNOGLOBULIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CELL COUNT; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NEUROLOGIC EXAMINATION; NEUROLOGICAL COMPLICATION; PARESTHESIA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA;

EID: 1542752270     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3603.2002236     Document Type: Article

References (26)

1. den Heijer JC, Peters ACB, van Gemert GW. Postinfectious meningoencephalitis complicating Mycoplasmapneumoniae in a child. J Neurol Neurosurg Psychiatry 1986; 49: 600-2.
2. Koskiniemi M. CNS manifestations associated with Mycoplasmapneumoniae infections: summary of cases at the University of Helsinky and review. Clin Infect Dis 1993; 17 (Suppl 1): S52-7.
3. Yesnick L. Central nervous system complications of primary atypical pneumonia. Arch Intern Med 1956; 97: 93.
4. Sterner G, Biberfeld G. Central nervous system complication of Mycoplasma pneumoniae infections. Scand J Infect Dis 1969; 1: 203-8.
5. Pönkä A. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis 1980; 12: 175-84.
6. Lerer RJ, Kalavsky SM. Central nervous system disease associated with Mycoplasma pneumoniae infection: report of five cases and review of the literature. Pediatrics 1973; 52: 658.
7. Mills RW, Schoolfield L. Acute transverse myelitis associated with Mycoplasmapneumoniae infection: a case report and review of the literature. Pediatr Infect Dis J 1992; 11: 228.
8. Ong ELC, Ellis ME, Yuill GM. Neurologic complication of Mycoplasmapneumoniae infection. Respir Med 1989; 83: 441.
9. Steele JC, Thanasophon S, Gladstone RM, Fleming PC. Mycoplasma pneumoniae as a determinant of the Guillain-Barré syndrome. Lancet 1969; 2: 719.
10. Jachnuck SJ, Gardner-Thorpe C, Clark F, Foster JB. A brainstem syndrome associated with Mycoplasma pneumoniae infection: a report of two cases. Postgrad Med J 1975; 51: 475-7.
11. Merkx H, de Keyser J, Ebinger G. Miller Fisher syndrome with Mycoplasma pneumoniae infection: report of a case. Clin Neurol Neurosurg 1994; 96: 96-9.
12. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol 1999; 100: 74-97.
13. Vinzio S, Andres E, Goichot B, Schlienger JL. Guillain Barré syndrome and Mycoplasma pneumoniae infection. Ann Med Intern (Paris) 2000; 151: 309-10.
14. Smith R, Eviatar L. Neurologic manifestations of Mycoplasma pneumoniae infections: diverse spectrum of diseases. Clin Pediatr 2000; 39: 195-201.
15. Yeh JH, Chen WH, Chen JR, Chiu HC. Miller Fisher syndrome with central involvement: successful treatment with plasmapheresis. Ther Apher 1999; 3: 69-71.
16. Pfausler B, Grubwieser G, Auckenthaler A, Rogenhofer H, Schmutzhard E. Multimodal therapy of Miller Fisher syndrome. Possible benefit of cerebrospinal fluid filtration. Nervenarzt 1997; 68: 1002-3.
17. Chin-Lun Y, Yuh-Jen W, Ching-Piao T. Miller Fisher syndrome: a hospital-based retrospective study. Eur Neurol 2000; 44: 79-85.
18. Turner B, Wills AJ. Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2000; 68: 790-1.
19. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001; 56: 1104-5.
20. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992; 31: 677-9.
21. Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 1993; 43: 414-7.
22. Willison HJ, Veitch J, Paterson G, Kennedy PGE. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993; 56: 204-6.
23. Riche G, Caudie C, Vial C, Bourrat C. Recurrent Miller Fisher syndrome and anti-GQ1b antibodies. Rev Med Intern 1998; 19: 192-5.
24. Caccavale A, Mignemi L. Acute onset of a bilateral areflexical mydriasis in Miller-Fisher syndrome: a rare neuro-ophthalmologic disease. J Neuroophthalmol 2000; 20: 61-2.
25. Ouhabi H, Bourazza A, Rouimi A, Boutaleb N, Mosseddaq R. Bilateral optic neuritis and ponto-mensencephalic involvement shown by MRI in Miller Fisher syndrome. Rev Neurol (Paris) 1998; 154: 780-2.
26. Giroud M, Mousson C, Chalopin JM, Rifle G, Dumas R. Miller Fisher syndrome and pontine abnormalities on MRI: a case report. J Neurol 1990; 237: 489-90.